Rasmus Irming Jølck

Corporate Officer/Principal presso Nanovi Radiotherapy A/S

Health Technology

Consumer Services

Profilo

Rasmus Irming Jølck is currently working as a Development Director at Nanovi Radiotherapy A.
Prior to this, he worked as a Principal at Technical University of Denmark.

Posizioni attive di Rasmus Irming Jølck

Società	Posizione	Inizio
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Corporate Officer/Principal	-

Tutte le posizioni attive di Rasmus Irming Jølck

Precedenti posizioni note di Rasmus Irming Jølck

Società	Posizione	Fine
Technical University of Denmark	Corporate Officer/Principal	03/11/2014

Vedi nel dettaglio l'esperienza di Rasmus Irming Jølck

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Rasmus Irming Jølck

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Health Technology